---
figid: PMC10311254__fonc-13-1204829-g001
figtitle: 'Unlocking the power of precision medicine for pediatric low-grade gliomas:
  molecular characterization for targeted therapies with enhanced safety and efficacy'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10311254
filename: fonc-13-1204829-g001.jpg
figlink: /pmc/articles/PMC10311254/figure/f1/
number: F1
caption: MAPK/ERK (green) and PI3K/AKT/mTOR (orange) signaling pathway. In red show
  the inhibitors and the alterations in gene that are causative to dysregulation of
  these pathways in pLGGs.
papertitle: 'Unlocking the power of precision medicine for pediatric low-grade gliomas:
  molecular characterization for targeted therapies with enhanced safety and efficacy.'
reftext: Selene Cipri, et al. Front Oncol. 2023;13:1204829.
year: '2023'
doi: 10.3389/fonc.2023.1204829
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: pediatric low-grade glioma | brain tumors | neuro-oncology | molecular diagnostic
  | clinical trials | targeted therapies | risk stratification | glioma
automl_pathway: 0.9455381
figid_alias: PMC10311254__F1
figtype: Figure
redirect_from: /figures/PMC10311254__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10311254__fonc-13-1204829-g001.html
  '@type': Dataset
  description: MAPK/ERK (green) and PI3K/AKT/mTOR (orange) signaling pathway. In red
    show the inhibitors and the alterations in gene that are causative to dysregulation
    of these pathways in pLGGs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - PTEN
  - MTOR
  - TSC1
  - CCL26
  - KRAS
  - NRAS
  - MTG1
  - BRAF
  - MAP2K1
  - MAPK3
  - MAPK1
  - NF1
---
